Downers Grove, IL – Coventry recently announced the release of its 2015 First Script® Drug Trends Analysis. The report provides a view into traditional Pharmacy Benefit Management (PBM) trends that align with other industry reports, but once again shares their fully transparent view into the total pharmacy experience.
A significant number of injured workers receive their medications outside the protective oversight available in a traditional retail pharmacy setting. Non-traditional dispensing channels, such as compounding pharmacies and physician dispensing, have created increasing risks to injured worker safety and outcomes overall. Our latest analysis focuses on patient safety as a shared responsibility. Given the collective challenges faced in managing pharmacy care in workers’ compensation, this message has never resonated more than it does right now.
By including all pharmaceutical transactions, we are able to strengthen our decision-support tools and focus our interventions to improve clinical outcomes and pricing opportunities. Our proactive efforts are having an impact:
- Last year overall cost per claim rose at half the pace seen in prior years
- Opioid cost per claim fell from 2014
- A drop in drug utilization helped offset an increase in cost per prescription
“The analysis also offers an examination of reduced Morphine Equivalent Dosing (MED) levels over the last three years as a meaningful sign of change,” said Betsy Robinson, senior vice president of product development and marketing. “Aggregate prescription data, risk-identification tools, as well as integrated communication with nurse case managers are helping drive these positive trends.”
For more information on Coventry’s review of pharmacy trends within workers’ compensation, click here: Coventry 2015 First Script Drug Trends Analysis (PDF).
Coventry is a WorkCompWire ad partner.
This is not a paid placement.